Breaking News Instant updates and real-time market news.

NTNX

Nutanix

$28.76

-0.53 (-1.81%)

06:13
11/26/19
11/26
06:13
11/26/19
06:13

Nutanix price target raised to $35 from $29 at Piper Jaffray

Piper Jaffray analyst James Fish raised his price target for Nutanix to $35 from $29 saying the company's fiscal Q1 upside was driven by the term-license transition, and its Q2 guide came in above expectations "despite fears of another guide-miss." The stock is up 20% post-earnings given the weak sentiment heading into the print, Fish tells investors in a research note titled "Making a Compelling Case for 'Comeback Player of the Year' in Infrastructure SW." The analyst keeps a Neutral rating on Nutanix shares.

  • 02

    Dec

  • 09

    Dec

  • 13

    Dec

  • 16

    Dec

NTNX Nutanix
$28.76

-0.53 (-1.81%)

11/04/19
PIPR
11/04/19
INITIATION
Target $29
PIPR
Neutral
Nutanix assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst James Fish assumed coverage of Nutanix (NTNX) with a Neutral rating and $29 price target. Competition, particularly from VMware (VMW), is a "major concern," Fish tells investors in a research note. Further, Nutanix's current model of spending more incremental dollars on sales and marketing than the incremental billings/revenue is not sustainable, and does not properly balance growth and margin, says the analyst. He would become more constructive on the shares with a return to "consistent execution."
11/20/19
OTRG
11/20/19
UPGRADE
OTRG
Positive
Nutanix upgraded to Positive from Mixed at OTR Global
OTR Global upgraded Nutanix to Positive from Mixed following checks that indicate an improvement in year-over-year sales and win rates during Q1 2020. The firm said customers are finding Nutanix's HCI solutions as simplistic, with market leadership helping to fill Q2 2020 pipelines.
11/26/19
STFL
11/26/19
NO CHANGE
Target $34
STFL
Hold
Nutanix price target raised to $34 from $22 at Stifel
Stifel analyst Brad Reback raised his price target for Nutanix to $34 from $22 saying the company last night posted a "clean print" with revenue and billings modestly above guidance, and issued a "solid" outlook for Q2. With these results, Nutanix "took another step in the right direction" in its ongoing efforts to reach a state of steady, profitable, growth, Reback tells investors in a research note. The analyst, however, keeps a Hold rating on the shares, believing it could take years before the company is steadily free cash flow positive.
11/26/19
KEYB
11/26/19
NO CHANGE
Target $42
KEYB
Overweight
Nutanix target raised to $42 on improved sales execution at KeyBanc
KeyBanc analyst Alex Kurtz raised his price target for Nutanix to $42 from $40 saying the company last night posted better than expected results. Nutanix's Americas division appears to have posted another quarter of improved execution led by enterprise, Kurtz tells investors in a research note. He keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ZG

Zillow

$40.54

-0.18 (-0.44%)

, SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ZG

Zillow

$40.54

-0.18 (-0.44%)

SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

PAA

Plains All American

$17.29

-0.01 (-0.06%)

PAGP

Plains GP Holdings

$17.37

0.01 (0.06%)

SSKN

Strata Skin Sciences

$2.20

0.04 (1.85%)

ZYME

Zymeworks

$41.25

-0.45 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 30

    Dec

  • 04

    Feb

MMM

3M

$169.82

-1.675 (-0.98%)

, PNC

PNC Financial

$153.68

-0.13 (-0.08%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MMM

3M

$169.82

-1.675 (-0.98%)

PNC

PNC Financial

$153.68

-0.13 (-0.08%)

M

Macy's

$14.96

-0.19 (-1.25%)

CVX

Chevron

$117.18

-0.8 (-0.68%)

HBIO

Harvard Bioscience

$2.83

-0.12 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 15

    Jan

QRVO

Qorvo

$109.72

3.04 (2.85%)

, SWKS

Skyworks

$104.55

3.15 (3.11%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

QRVO

Qorvo

$109.72

3.04 (2.85%)

SWKS

Skyworks

$104.55

3.15 (3.11%)

FATE

Fate Therapeutics

$19.69

6.05 (44.35%)

WING

Wingstop

$84.26

4.04 (5.04%)

HUN

Huntsman

$23.31

0.48 (2.10%)

FTV

Fortive

$74.68

1.82 (2.50%)

DOW

Dow Inc.

$53.29

0.04 (0.08%)

KRA

Kraton

$23.96

0.92 (3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

TPR

Tapestry

$25.85

0.305 (1.19%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Options
Upside February calls see heavy trading in Tapestry »

Upside February calls see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

, GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

10:19
12/09/19
12/09
10:19
12/09/19
10:19
Hot Stocks
SpringsWorks reports Glaxo presentation of preclinical data on nirogacestat »

SpringWorks Therapeutics…

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/09/19
12/09
10:17
12/09/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$44.49

3.56 (8.70%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Hot Stocks
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$22.25

7.85 (54.51%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Forty Seven announces preclinical proof-of-concept data for FSI-174 »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

NKTR

Nektar

$22.00

1.55 (7.58%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Nektar announces presentation of data for NKTR-255 at ASH »

Nektar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UPS

UPS

$116.87

-0.67 (-0.57%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
UPS reports expansion of UPS Worldwide Express, Express Plus across 40 countries »

UPS announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$60.30

-0.69 (-1.13%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Options
Centene put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Breaking Hot Stocks news story on Constellation Pharmaceuticals »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ACHN

Achillion

$6.19

0.02 (0.32%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Achillion reports 'positive' data from Phase 2 danicopan, eculizumab study »

Achillion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ATRA

Atara Biotherapeutics

$14.24

0.25 (1.79%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Hot Stocks
Atara reports updated long-term clinical results from Tab-cel EBV+ PTLD study »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$102.78

-0.525 (-0.51%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Conference/Events
Globant management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 16

    Jan

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Hot Stocks
Constellation Pharmaceuticals provides update on MANIFEST clinical trial »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

DTIL

Precision BioSciences

$18.00

-1.66 (-8.44%)

10:11
12/09/19
12/09
10:11
12/09/19
10:11
Hot Stocks
Breaking Hot Stocks news story on Precision BioSciences »

Precision BioSciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

MTEM

Molecular Templates

$12.23

(0.00%)

10:10
12/09/19
12/09
10:10
12/09/19
10:10
Hot Stocks
Molecular Templates announces presentations of two posters at ASH »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.72

0.545 (1.75%)

10:10
12/09/19
12/09
10:10
12/09/19
10:10
Conference/Events
Avis Budget management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

XNCR

Xencor

$41.27

0.25 (0.61%)

10:08
12/09/19
12/09
10:08
12/09/19
10:08
Hot Stocks
Xencor presents Initial Data from Phase 1 Study of XmAb 13676 »

Xencor announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

SGEN

Seattle Genetics

$117.12

-0.4 (-0.34%)

, TAK

Takeda Pharmaceutical

$20.12

-0.15 (-0.74%)

10:08
12/09/19
12/09
10:08
12/09/19
10:08
Hot Stocks
Seattle Genetics, Takeda announce additional analyses of Adcetris »

Seattle Genetics (SGEN)…

SGEN

Seattle Genetics

$117.12

-0.4 (-0.34%)

TAK

Takeda Pharmaceutical

$20.12

-0.15 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

DTIL

Precision BioSciences

$19.88

0.22 (1.12%)

10:06
12/09/19
12/09
10:06
12/09/19
10:06
Hot Stocks
Breaking Hot Stocks news story on Precision BioSciences »

Precision BioSciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ARMK

Aramark

$42.70

-0.32 (-0.74%)

10:06
12/09/19
12/09
10:06
12/09/19
10:06
Conference/Events
Aramark management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

INTC

Intel

$56.80

(0.00%)

10:04
12/09/19
12/09
10:04
12/09/19
10:04
Hot Stocks
Intel reveals what it believes to be a first-of-its-kind cryogenic control chip »

Intel Labs unveiled what…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.